Keywords: serono, 3rd-qtr, sales, rise, rebif, says, its
Serono's 3rd-qtr 2006 sales rise 8.4% on Rebif
Article | 30 October 2006
Serono says that its third-quarter 2006 revenues increased 9.5% on the like, year-ago period, to $699.1 million, as product sales grew 8.4% to $619.2 million. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
